Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | 177Lu-RAD204 |
Synonyms | |
Therapy Description |
Limited information is currently available on 177Lu-RAD204, a putative radiotherapy targeting CD274 (PD-L1) (Mar 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
177Lu-RAD204 | 177Lu RAD204|177LuRAD204 | PD-L1/PD-1 antibody 121 | Limited information is currently available on 177Lu-RAD204, a putative radiotherapy targeting CD274 (PD-L1) (Mar 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06305962 | Phase I | 177Lu-RAD204 | 177Lu-anti-PD-L1 sdAb in Metastatic Non-small Cell Lung Cancer | Recruiting | AUS | 0 |